Mentor Moms+ Study

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
HIVAlcohol Consumption
Interventions
BEHAVIORAL

MM+

Participants in both study arms will receive clinic-based HIV counseling, including urine tenofovir testing and biofeedback counseling on recent PrEP or ART use. Activities unique to women enrolled in the intervention arm include: Brief motivational interviewing sessions with a mentor mother focusing on 1) EtG testing and biofeedback on recent alcohol use, 2) counseling and mentorship on ways to reduce alcohol use.

BEHAVIORAL

Enhanced HIV attention control (eSOC)

Participants in the enhanced HIV attention control arm (comparison group) will attend a similar number of study visits within the same time frame as intervention participants (5-6 sessions during 6-month timeframe including both pregnancy and postpartum). Control arm sessions will consist of one-on-one educational counseling on HIV risk, partner HIV testing modalities, as well as conducting PrEP/ART urine assay testing followed by real-time in-clinic adherence counseling delivered privately (different from study nurses delivering PrEP/ART biofeedback in MM+ intervention arm to avoid contamination), all coinciding with routine ANC visits.

Trial Locations (1)

Unknown

Saldanha Bay Municipality Clinic, Cape Town

All Listed Sponsors
collaborator

University of Cape Town

OTHER

collaborator

San Diego State University

OTHER

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

University of California, Los Angeles

OTHER

NCT06962592 - Mentor Moms+ Study | Biotech Hunter | Biotech Hunter